… Metabolic syndrome (MS) is a growing epidemic and a risk factor for the development of
hepatocellular carcinoma (HCC). This study investigated the long-term outcomes of liver …

… factors besides HPV such as metabolic syndrome (MetS) that … , we describe evidence
showing that Metabolic syndrome (MetS) … compared to squamous cell carcinoma. For instance, …

… and other components of metabolic syndrome in the occurrence of RCC. Diabetes mellitus
(DM), one of the main consequences of metabolic syndrome, appears much more often in …

… Patients with renal cell carcinoma (RCC) and MetS patients had shorter progression-free
survival. Due to the negative impact of MetS in cancer progression, it is emphasized that …

… of the metabolic syndrome, we also collected risk estimates for each single component
and compared them with the estimates for metabolic syndrome obtained in the same studies. …

… metabolic syndrome components, especially dyslipidemia, as risk factors for pancreatic
adenocarcinoma. The results of this study provide evidence that certain metabolic syndrome com…

… Metabolic syndrome is conferred as central obesity, dyslipidemia, hyperglycemia, insulin
resistance and hypertension. Metabolic … We found that metabolic syndromes and together with …

… Metabolic syndrome is a newly recognized, but important, … (which is associated with
metabolic syndrome). Current radiation … in a patient with metabolic syndrome without significant …

… The presence of metabolic syndrome in relation to group affiliation was statistically significant
(p=0.048) (Table 4). By calculating OR (odds ratio), examinees with MetSy were 2.62 times …

… The results of evaluating prognostic value of MetS in localized clear cell renal cell carcinoma
(ccRCC) (12, 13) were diametrically opposed. As for UTUC, a recent study based on the …